CONTROVERSIES IN DETERMINATION OF EPOETIN (RECOMBINANT-HUMAN-ERYTHROPOIETIN) DOSAGES

被引:11
作者
ABRAHAM, PA [1 ]
STPETER, WL [1 ]
REDICKILL, KA [1 ]
HALSTENSON, CE [1 ]
机构
[1] UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA
关键词
D O I
10.2165/00003088-199222060-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[No abstract available]
引用
收藏
页码:409 / 415
页数:7
相关论文
共 48 条
  • [1] ABRAHAM PA, 1991, J AM SOC NEPHROL, V2, P927
  • [2] ANDROGENS POTENTIATE THE EFFECTS OF ERYTHROPOIETIN IN THE TREATMENT OF ANEMIA OF END-STAGE RENAL-DISEASE
    BALLAL, SH
    DOMOTO, DT
    POLACK, DC
    MARCIULONIS, P
    MARTIN, KJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (01) : 29 - 33
  • [3] BOMMER J, 1988, LANCET, V2, P406
  • [4] BOMMER J, 1991, CONTRIB NEPHROL, V88, P136
  • [5] HYPERTENSION FOLLOWING ERYTHROPOIETIN THERAPY IN ANEMIC HEMODIALYSIS-PATIENTS
    BUCKNER, FS
    ESCHBACH, JW
    HALEY, NR
    DAVIDSON, RC
    ADAMSON, JW
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (12) : 947 - 955
  • [6] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY ON BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS
    BURGESS, ED
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 1991, 11 (01) : 23 - 26
  • [7] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS
    CASATI, S
    PASSERINI, P
    CAMPISE, MR
    GRAZIANI, G
    CESANA, B
    PERISIC, M
    PONTICELLI, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605): : 1017 - 1020
  • [8] COTES PM, 1989, Q J MED, V70, P113
  • [9] LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS
    DUFF, DR
    GOLPER, TA
    SLOAN, RS
    BRIER, ME
    ARONOFF, GR
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) : 60 - 64
  • [10] DRUG-THERAPY - ERYTHROPOIETIN
    ERSLEV, AJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) : 1339 - 1344